Experience

YUKIN THERAPEUTICS

• France
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Corporate Manager

  • Jan 2021 - Present

• Project Manager

  • Jun 2019 - Dec 2021

  Yukin is a biotech company developing a small molecule targeting an immune-checkpoint inhibitor (NIK) for cancer therapy. Incorporated in June 2018, supported by Advent France Biotechnology and Medicxi, €3,3m raised in the seed Series.



Alderaan Biotechnology

• France
• Biotechnology Research
• 1 - 100 Employee

• Corporate Manager

  • Jan 2021 - Nov 2022

• Project Manager

  • Jun 2019 - Jan 2021

  Alderaan is a biotech company developing antibodies for the treatment of cancer with mechanism of action aiming at the Treg depletion and the NK cell modulation. Incorporated in July 2017, supported by Advent France Biotechnology, €18,5m raised in Series A.



Tridek-One

• France
• Biotechnology Research
• 1 - 100 Employee

• Project Manager

  • Jun 2018 - Feb 2020

  Tridek-One is a biotech company developing first in class immunomodulatory compounds (peptide and antibody) for immunoinflammatory diseases. Incorporated in June 2018, supported by Advent France Biotechnology and Advent Life Science, €3.5m raised in the seed Series. Tridek-One is a biotech company developing first in class immunomodulatory compounds (peptide and antibody) for immunoinflammatory diseases. Incorporated in June 2018, supported by Advent France Biotechnology and Advent Life Science, €3.5m raised in the seed Series.



Groupe ÉLÉPHANT VERT

• Business Developer

  • May 2016 - Apr 2018

  Elephant vert is an Agri-biotech company (360 employees) developing and commercializing bio-solutions: bio-fertilizer, bio-stimulant, bio-pesticide. Negotiating development and distribution partnership with R&D lab and SMEs (€28m+ of potential investment). Creating NILE, an Elephant Vert subsidiary dedicated to innovation. Company (NILE) creation: Business development strategy: setting-up the short and mid term strategy for innovation scouting, defining the target market and the desired technology profile, developing commercial tools Organizational leadership: editing partnership contract draft, setting-up innovation evaluation document process, making recommendation regarding the technical support tools Business development: Deal origination: Identifying and meeting potential partners (university lab, tech transfer office, SMEs). Networking at conventions and conferences Setting-up partnerships: Defining the partnership framework (industrial development, legal status, product registration, intellectual property), product positioning, forecasting potential revenue and valuation. Negotiating contract: defining the remuneration structure in a financial (up-front, milestone, royalty) and industrial (toll manufacturing, distribution) point of view.



SATT idfinnov

• Business analyst

  • Oct 2013 - May 2016

  Idf innov is a technology transfer office (45 employees) bringing academic innovations to market. €68m in assets under management. Market analysis and investment recommendation reports (in a team) on more than 20 projects (€4m+ investment). Various innovations ranging from R&D tools to new medications and from eHealth to medical devices. Investment analysis: Market analysis: conduct market research through scientific publications, patents, clinical trials, key opinion leader (KOL) interviews and commercial products to position the invention in the market. Business Development strategy: set up commercial strategy for technology transfer (proof of concept feedback, scientific marketing, value chain positioning) Business development: Deal origination: Identify and meet industrial partners Forecast potential revenue and valuation Selected projects: Term sheet negotiation and contract drafting for a pharma R&D project A research-use antibody: out-licensing process (term sheet negotiation, contract)



Texcell

• France
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Area Sales Manager Immunoprofiling

  • Jan 2013 - Oct 2013

  Texcell is a contract research organization (CRO) specialized in viral safety and immunology studies. Clients are pharma/biotech industry, agro business and cosmetic industry. 50 employees with €6m revenue. Business Development: identified and research new business opportunities. Customer Relationship: developed and maintained relationships with new and existing clients, serviced client accounts. Negotiation: analyzed needs, calculated quotations, negotiated tender and contract terms and conditions



Novartis

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Sales & marketing strategic analyst

  • Feb 2012 - Aug 2012

  Worked on three products in the pulmonology field (Onbrez®, COPD; Xolair® Severe asthma and TOBI®, cystic fibrosis). Market analysis: built market surveys (qualitative and quantitative study, focus groups), managed sales data (evolution of market share, market penetration), made strategic recommendations to operational marketing team Sales force effectiveness: set up and updated sales indicators, presented strategic recommendations to the sales team Worked on three products in the pulmonology field (Onbrez®, COPD; Xolair® Severe asthma and TOBI®, cystic fibrosis). Market analysis: built market surveys (qualitative and quantitative study, focus groups), managed sales data (evolution of market share, market penetration), made strategic recommendations to operational marketing team Sales force effectiveness: set up and updated sales indicators, presented strategic recommendations to the sales team

• Research analyst: The karyology in bio production

  • May 2011 - Jul 2011

  Scientific research & Regulatory watch: studied cytogenetic analysis tools and guidelines about the use of cells in bio production and advanced therapies (WHO, ICH, FDA, EMEA) Market study : analyzed trends, identified competitors, targeted potential customer, assessed market size Budget study: evaluated implementation costs, drew up business offer, estimated return of investment Scientific research & Regulatory watch: studied cytogenetic analysis tools and guidelines about the use of cells in bio production and advanced therapies (WHO, ICH, FDA, EMEA) Market study : analyzed trends, identified competitors, targeted potential customer, assessed market size Budget study: evaluated implementation costs, drew up business offer, estimated return of investment



TcLand Expression

• France
• Pharmaceutical Manufacturing

• Research analyst: Clinical study market

  • Jul 2010 - Aug 2010

  Customer relationship management update (Salesforce) based on selected clinical study to help business development Customer relationship management update (Salesforce) based on selected clinical study to help business development